Skip to main content

[vc_row][vc_column width="1/4"][vc_single_image image="19051" img_size="medium" alignment="center" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]A research study conducted in both Denmark and the United States found a strong link between skin and lip cancer rates and the use of hydrochlorothiazide, one of the most popular blood pressure medicines in the world. The...

[vc_row][vc_column width="1/4"][vc_single_image image="63480" img_size="medium" alignment="center" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""] Enjoying a glass of fine wine by the fireside is a normal part of a Holiday party. But at this time of year, it’s wise to be well aware of the scientific community’s numerous studies on the association...

[vc_row][vc_column][vc_single_image image="67628" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Researchers have found that the anti-tapeworm drug nitazoxanide (NTZ) may also offer hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters....

[vc_row][vc_column][vc_column_text css=""]CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this...